EcoDrugPlus

Histone Deacetylase 4-Like

Ensembl ID : ENSOKIG00005006027
Gene Symbol: LOC109906801
2 Cross references
194 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSOKIG00005005672
Gene Symbol: HDAC5
1 Cross references
191 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSOKIG00005007390
Gene Symbol: HDAC5
3 Cross references
191 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSOKIG00005005315
Gene Symbol: HDAC6
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOKIG00005018872
Gene Symbol: LOC109891737
2 Cross references
188 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOKIG00005026713
Gene Symbol: HDAC7
1 Cross references
184 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOKIG00005034580
Gene Symbol: LOC109891643
2 Cross references
186 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOKIG00005018759
Gene Symbol: HDAC7
1 Cross references
183 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSOKIG00005045782
Gene Symbol: HDAC8
3 Cross references
204 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSOKIG00005017050
Gene Symbol: HCN4
1 Cross references
213 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSOKIG00005050340
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSOKIG00005031084
Gene Symbol: IKBKB
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).